Home LiteratureArticle Details
PMID: 6607218 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Generation of chemotactic activity in serum by Haemophilus influenzae type b.

Infection and immunity ·Vol. 43 ·No. 2 ·1984-02-00 ·Pages 593-9

Tosi MF, Kaplan SL, Mason EO, Buffone GJ, Anderson DC

Abstract

Studies were performed to characterize chemotactic activity generated by Haemophilus influenzae type b (HiTb) in serum or elaborated independent of serum. Neutrophil aggregometry, Sephadex G-75 gel chromatography, and anti-C5 neutralization studies were used to demonstrate that the complement fragment C5a represented the major chemotactic moiety derived from HiTb-serum interactions. HiTb elaborated minimal chemotactic activity independently. Maximal C5a generation by HiTb as measured by neutrophil response in chemotaxis, shape change, and aggregation assays required specific antibody to the capsular polysaccharide, polyribosyl ribitol phosphate (PRP). Significantly more C5a was generated in pooled normal human serum containing high titers of anti-PRP (determined by an enzyme-linked immunosorbent assay) than in hypogammaglobulinemic serum. Furthermore, C5a generated in hypogammaglobulinemic serum reconstituted with purified high-titer immunoglobulin G, hyperimmune rabbit serum or heat-inactivated normal human serum was comparable to that generated in normal human serum. Absorption of antibody with PRP versus whole HiTb showed a contribution by non-PRP-directed antibody. As shown with the use of C4-deficient guinea pig serum, C5a generation occurred via the alternative complement pathway in nonimmune serum, and activation of the alternative complement pathway was facilitated by specific anti-PRP. C5a generation in test sera was proportional to its opsonic activity for HiTb as assessed by a luminol-chemiluminescence assay. Overall low levels of C5a activity were observed in 13 pediatric patient serum samples obtained during the acute phase of HiTb meningitis, and no pulmonary symptoms or radiographic abnormalities consistent with a leukocyte aggregation syndrome were observed in these patients.

MeSH Terms
Antibodies, Bacterial/immunology Chemotaxis Complement C5/biosynthesis,immunology Complement C5a Enzyme-Linked Immunosorbent Assay Haemophilus influenzae/immunology Humans Phagocytosis Polysaccharides/immunology
Chemicals
Antibodies, Bacterial Complement C5 Polysaccharides polyribitol phosphate Complement C5a
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tosi M F
Kaplan S L
Mason E O
Buffone G J
Anderson D C
References (30)
30 references, click to expand
  1. Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage.
    Semin Hematol. 1979 Apr;16(2):140-7 PMID: 384520
  2. Motility and adhesiveness in human neutrophils. Effects of chemotactic factors.
    J Clin Invest. 1979 Feb;63(2):221-9 PMID: 372238
  3. Haemophilus influenzae bacteremia and meningitis in infant primates.
    J Lab Clin Med. 1980 Mar;95(3):450-62 PMID: 6766493
  4. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.
    J Infect Dis. 1980 Mar;141(3):370-81 PMID: 6988524
  5. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.
    Lancet. 1980 May 3;1(8175):947-9 PMID: 6103300
  6. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.
    Infect Immun. 1979 Nov;26(2):435-40 PMID: 397927
  7. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses.
    Rev Infect Dis. 1980 Mar-Apr;2(2):293-318 PMID: 6994210
  8. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.
    J Clin Invest. 1980 Aug;66(2):167-75 PMID: 6249846
  9. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.
    J Clin Microbiol. 1981 Mar;13(3):532-9 PMID: 6972383
  10. Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.
    J Lab Clin Med. 1981 Dec;98(6):823-30 PMID: 7310225
  11. Differential complement resistance mediates virulence of Haemophilus influenzae type b.
    Infect Immun. 1982 Jan;35(1):95-104 PMID: 6976328
  12. Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.
    Lancet. 1982 Feb 13;1(8268):366-8 PMID: 6120351
  13. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    J Immunol. 1982 Apr;128(4):1772-5 PMID: 6977569
  14. Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro.
    Infect Immun. 1982 Nov;38(2):563-72 PMID: 6815096
  15. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
    J Clin Invest. 1982 Dec;70(6):1177-83 PMID: 7174788
  16. Enzyme-linked immunosorbent assay for detection of capsular antibodies against Haemophilus influenzae type b: comparison with radioimmunoassay.
    J Clin Microbiol. 1983 Nov;18(5):1201-4 PMID: 6605975
  17. THE FRACTIONATION OF PROTEIN MIXTURES BY LINEAR POLYMERS OF HIGH MOLECULAR WEIGHT.
    Biochim Biophys Acta. 1964 Mar 16;82:463-75 PMID: 14148814
  18. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    J Exp Med. 1968 Aug 1;128(2):259-75 PMID: 4873021
  19. The isolation of IgG from mammalian sera with the aid of caprylic acid.
    Arch Biochem Biophys. 1969 Nov;134(2):279-84 PMID: 4982185
  20. Human serum activities against Hemophilus influenzae, type b.
    J Clin Invest. 1972 Jan;51(1):31-8 PMID: 4536614
  21. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
    J Exp Med. 1973 Feb 1;137(2):387-410 PMID: 4568301
  22. Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.
    Infect Immun. 1973 Sep;8(3):488-90 PMID: 4542337
  23. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.
    J Immunol. 1974 Jun;112(6):2047-54 PMID: 4596695
  24. The in vitro assessment of leucocyte chemotaxis.
    Antibiot Chemother (1971). 1974;19:112-25 PMID: 4618736
  25. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.
    Infect Immun. 1976 Oct;14(4):882-7 PMID: 1086832
  26. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    J Clin Invest. 1977 Jul;60(1):260-4 PMID: 874088
  27. Detection and quantitation of bacteremia in childhood.
    J Pediatr. 1977 Nov;91(5):719-21 PMID: 333075
  28. Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity.
    Infect Immun. 1978 Aug;21(2):619-26 PMID: 80382
  29. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae.
    J Infect Dis. 1978 Oct;138(4):427-36 PMID: 309494
  30. Chemotaxigenesis by cell surface components of Staphylococcus aureus.
    Infect Immun. 1979 Oct;26(1):57-63 PMID: 500215
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1984-02-00
Pages
593-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264340
Subset
IM
Grants
PHS HHS · KO 4 00501-02 · United States
NIAID NIH HHS · R 01 AI/AM 19031-02 · United States
NCRR NIH HHS · RR 05425-21 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]